chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 4.0
Sex: M
Vaccine: FLU3
Symptoms: Cough, Medication error, Pyrexia, Upper respiratory tract infection
Clinical narrative: A report was received from a health care professional on 12/16/03 concerning a vaccinee aged less than 4 years of age and of unknown gender who was inadvertently administered Fluvirin and experienced fever on an unknown date. On an unknown date, the vaccinee was inadvertently administered Fluvirin and experienced fever. There is no information available on the outcome of this event. There was insufficient information to determine the reporter's causality assessment. Update 3/26/04: A follow up report was received from a health care professional indicating that a 3 year old male vaccinee experienced symptoms of upper respiratory tract infection, fever, and cough 2 months after inadvertently receiving 0.5ml Fluvirin on 11/24/03. The vaccinee recovered after 7 days. On 1/20/04, the vaccinee tested positive for influenza A and negative for influenza B. Follow up pending.
Age: 1.5
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 12/16/03 concerning an 18 month old male vaccinee who inadvertently received Fluvirin on an unknown date in December 2003. On an unknown date in December 2003, a vaccinee was inadvertently vaccinated with Fluvirin. No adverse events had occurred at the time of this report. There is insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 1.5
Sex: U
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 12/16/03 concerning an 18 month old vaccinee of unknown gender who inadvertently received Fluvirin on an unknown date in December 2003. On an unknown date in December 2003 a vaccinee was inadvertently administered Fluvirin. No adverse events have occurred as a result of this, at the time of this report. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 8.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 12/17/03 concerning an 8 year old male vaccinee who inadvertently received a sub-optimal dose of Fluvirin on 12/15/03. On 12/15/03, a vaccinee inadvertently received a dose of 0.25ml of Fluvirin. No adverse events had occurred as a result at the time of this report. There was insufficient information to determine the reporter's causality assessment. Update 3/15/04: Further information was received from a health care professional indicating that the vaccinee did not experience any adverse reaction. The vaccinee did not contract influenza and he later received the full dosage of Fluvirin in mid-January. No follow up pending. All information received.
Age: 49.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Urticaria
Clinical narrative: A report was received from a health care professional on 12/17/03 concerning a 49 year old female vaccinee who experienced a red, raised, painful area at the injection site within two hours of receiving Fluvirin on an unspecified date in October 2002. On an unspecified date in October 2002, the vaccinee experienced a red, raised, painful 5cm area at the injection site. The reaction resolved without medical intervention within 2 to 3 days. There was insufficient information to determine the reporter's causality assessment. Update 2/23/04: Further information received from a health care professional indicated that the vaccinee developed a round raised wheal 30 minutes following vaccination, which resolved 3 to 4 days later. The vaccinee did not have any previous exposure to Fluvirin. The reporter has assessed the relationship of the vaccination to the round raised wheal as probable. Follow up pending.
Age: 4.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/18/03 concerning a 4 year old vaccinee of unknown gender who inadvertently received a sub-optimal dose of Fluvirin on 11/11/03. On 11/11/03 the vaccinee received 0.25ml Fluvirin. The vaccinee did not exhibit any adverse symptoms at the time of reporting. There was insufficient information to determine the reporter's causality assessment. Update 1/19/04: A follow up report was received from a health care professional indicating that the vaccinee received a sub-optimal dose of Fluvirin on 11/10/03 approximately. No follow up pending. All information received.
Age: 4.0
Sex: F
Vaccine: FLU3
Symptoms: Erythema, Oedema peripheral
Clinical narrative: A report was received from a health professional on 12/17/03 concerning a 4 year old female vaccinee who experienced swelling and redness that began at the back of her left hand and spread to her left forearm 3-4 hours after receiving Fluvirin vaccine on 12/16/03. On 12/16/03 the vaccinee experienced swelling and redness that started at the back of her left hand and spread to her left forearm. The vaccinee did not experience pruritus or pain. The swelling and redness of her left forearm resolved on 12/17/03. However, the vaccinee still complained of redness at the back of her hand. The vaccinee did not receive any treatments. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 1.8
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 12/17/03 concerning a 22 month old female vaccinee who inadvertently received Fluvirin vaccine on 12/17/03. On 12/17/03 the vaccinee was administered 0.25ml Fluvirin. No adverse events were reported at the time of the report. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 2.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 12/17/03 concerning a 2.5 year old female vaccinee who inadvertently received Fluvirin vaccine on 12/17/03. On 12/17/03 the vaccinee was administered 0.5ml Fluvirin. The vaccinee had not exhibited any signs or symptoms of an adverse event at the time of the report. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 79.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/11/03 concerning an unspecified number of vaccinees who inadvertently received 1ml of Fluvirin on an unspecified date. On an unspecified date an unspecified number of vaccinees received 1ml of Fluvirin. No adverse symptoms were exhibited at the time of reporting. There was insufficient information information to determine the reporter's causality assessment. Follow up pending. Update 12/4/03: An update report was received from a health care professional concerning a 79 year old female vaccinee who inadvertently received 1ml Fluvirin SC on 10/31/03. On 10/31/03 the vaccinee inadvertently received Fluvirin SC. No adverse symptoms were exhibited at the time of reporting. No follow up pending.
Age: 86.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/11/03 concerning an unspecified number of vaccinees who inadvertently received 1ml of Fluvirin on an unspecified date. On an unspecified date an unspecified number of vaccinees received 1ml of Fluvirin. No adverse symptoms were exhibited at the time of reporting. There was insufficient information to determine the reporter's causality assessment. Follow up pending. Update 12/4/03: An update report was received from a health care professional concerning an 86 year old female vaccinee who inadvertently received 1ml Fluvirin SC on 10/31/03. On 10/31/03 the vaccinee inadvertently received Fluvirin SC. No adverse symptoms were exhibited at the time of reporting. No follow up pending.
Age: 93.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/11/03 concerning an unspecified number of vaccinees who inadvertently received 1ml of Fluvirin on an unspecified date. On an unspecified date an unspecified number of vaccinees received 1ml of Fluvirin. No adverse symptoms were exhibited at the time of reporting. There was insufficient information to determine the reporter's causality assessment. Follow up pending. Update 12/4/03: An update report was received from a health care professional concerning a 93 year old female vaccinee who inadvertently received 1ml Fluvirin SC on 10/31/03. On 10/31/03 the vaccinee inadvertently received Fluvirin SC. No adverse symptoms were exhibited at the time of reporting. No follow up pending.
Age: 78.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/11/03 concerning an unspecified number of vaccinees who inadvertently received 1ml of Fluvirin on an unspecified date. On an unspecified date an unspecified number of vaccinees received 1ml of Fluvirin. No adverse symptoms were exhibited at the time of reporting. There was insufficient information to determine the reporter's causality assessment. Follow up pending. Update 12/4/03: An update report was received from a health care professional concerning a 78 year old female vaccinee who inadvertently received 1ml Fluvirin SC on 10/31/03. On 10/31/03 the vaccinee inadvertently received Fluvirin SC. No adverse symptoms were exhibited at the time of reporting. No follow up pending.
Age: 96.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/11/03 concerning an unspecified number of vaccinees who inadvertently received 1ml of Fluvirin on an unspecified date. On an unspecified date an unspecified number of vaccinees received 1ml of Fluvirin. No adverse symptoms were exhibited at the time of reporting. There was insufficient information to determine the reporter's causality assessment. Follow up pending. Update 12/4/03: An update report was received from a health care professional concerning a 96 year old female vaccinee who inadvertently received 1ml Fluvirin SC on 10/31/03. On 10/31/03 the vaccine inadvertently received Fluvirin SC. No adverse symptoms were exhibited at the time of reporting. No follow up pending.
Age: 92.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/11/03 concerning an unspecified number of vaccinees who inadvertently received 1ml of Fluvirin on an unspecified date. On an unspecified date an unspecified number of vaccinees received 1ml of Fluvirin. No adverse symptoms were exhibited at the time of reporting. There was insufficient information to determine the reporter's causality assessment. Follow up pending. Update 12/4/03: An update report was received from a health professional concerning a 92 year old female vaccine who inadvertently received 1ml Fluvirin SC on 10/31/03. On 10/31/03 the vaccinee inadvertently received Fluvirin SC. No adverse symptoms were exhibited at the time of reporting. No follow up pending.
Age: 92.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/11/03 concerning an unspecified number of vaccinees who inadvertently received 1ml of Fluvirin on an unspecified date. On an unspecified date an unspecified number of vaccines received 1ml of Fluvirin. No adverse symptoms were exhibited at the time of reporting. There was insufficient information to determine the reporter's causality assessment. Follow up pending. Update 12/4/03: An update report was received from a health care professional concerning a 92 year old female vaccinee who inadvertently received 1ml Fluvirin SC on 10/31/03. On 10/31/03 the vaccinee inadvertently received Fluvirin SC. No adverse symptoms were exhibited at the time of reporting. No follow up pending.
Age: 82.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/11/03 concerning an unspecified number of vaccinees who inadvertently received 1ml of Fluvirin on an unspecified date. On an unspecified date an unspecified number of vaccinees received 1ml of Fluvirin. No adverse symptoms were exhibited at the time of reporting. There was insufficient information to determine the reporter's causality assessment. Follow up pending. Update 12/4/03: An update report was received from a health care professional concerning an 82 year old male vaccinee who inadvertently received 1ml Fluvirin SC on 10/31/03. On 10/31/03 the vaccinee inadvertently received Fluvirin SC. No adverse symptoms were exhibited at the time of reporting. No follow up pending.
Age: 34.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/11/03 concerning an unspecified number of vaccinees who inadvertently received 1ml of Fluvirin on an unspecified date. On an unspecified date an unspecified number of vaccinees received 1ml of Fluvirin. No adverse symptoms were exhibited at the time of reporting. There was insufficient information to determine the reporter's causality assessment. Follow up pending. Update 12/4/03: An update report was received from a health care professional concerning a 34 year old male vaccinee who inadvertently received 1ml Fluvirin SC on 10/31/03. On 10/31/03 the vaccinee inadvertently received Fluvirin SC. No adverse symptoms were exhibited at the time of reporting. No follow up pending.
Age: 77.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/11/03 concerning an unspecified number of vaccinees who inadvertently received 1ml of Fluvirin on an unspecified date. On an unspecified date an unspecified number of vaccinees received 1ml of Fluvirin. No adverse symptoms were exhibited at the time of reporting. There was insufficient information to determine the reporter's causality assessment. Follow up pending. Update 12/4/03: An update report was received from a health care professional concerning a 77 year old male vaccinee who inadvertently received 1ml Fluvirin SC on 10/31/03. On 10/31/03 the vaccinee inadvertently received Fluvirin SC. No adverse symptoms were exhibited at the time of reporting. No follow up pending.
Age: 76.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/11/03 concerning an unspecified number of vaccinees who inadvertently received 1ml of Fluvirin on an unspecified date. On an unspecified date an unspecified number of vaccinees received 1ml of Fluvirin. No adverse symptoms were exhibited at the time of reporting. There was insufficient information to determine the reporter's causality assessment. Follow up pending. Update 12/4/03: An update report was received from a health care professional concerning a 76 year old male vaccinee who inadvertently received 1ml Fluvirin SC on 10/31/03. On 10/31/03 the vaccinee inadvertently received Fluvirin SC. No adverse symptoms were exhibited at the time of reporting. No follow up pending.
Age: 76.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/10/03 concerning an unspecified number of vaccinees who inadvertently received 1ml of Fluvirin on an unspecified date. On an unspecified date an unspecified number of vaccinees received 1ml of Fluvirin. No adverse symptoms were exhibited at the time of reporting. There was insufficient information to determine the reporter's causality assessment. Follow up pending. Update 12/4/03: An update reported was received from a health care professional concerning a 76 year old male vaccinee who inadvertently received 1ml Fluvirin SC on 10/31/03. On 10/31/03 the vaccinee inadvertently received Fluvirin SC. NO adverse symptoms were exhibited at the time of reporting. No follow up pending.
Age: 36.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/11/03 concerning an unspecified number of vaccinees who inadvertently received 1ml of Fluvirin on an unspecified date. On an unspecified date an unspecified number of vaccinees received 1ml of Fluvirin. No adverse symptoms were exhibited at the time of reporting. There was insufficient information to determine the reporter's causality assessment. Follow up pending. Update 12/4/03: An update report was received from a health care professional concerning a 36 year old male vaccinee who inadvertently received 1ml Fluvirin SC on 10/31/03. On 10/31/03 the vaccinee inadvertently received Fluvirin SC. No adverse symptoms were exhibited at the time of reporting. No follow up pending.
Age: 100.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/11/03 concerning an unspecified number of vaccinees who inadvertently received 1ml of Fluvirin on an unspecified date. On an unspecified date an unspecified number of vaccinees received 1ml of Fluvirin. No adverse symptoms were exhibited at the time of reporting. There was insufficient information to determine the reporter's causality assessment. Follow up pending. Update 12/4/03: An update report was received from a health care professional concerning a 100 year old female vaccinee who inadvertently received 1ml Fluvirin SC on 10/31/03. On 10/31/03 the vaccinee inadvertently received Fluvirin SC. No adverse symptoms were exhibited at the time of reporting. No follow up pending.
Age: 5.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 12/17/03 concerning a 5 year old female vaccinee who inadvertently received a sub-optimal dose of Fluvirin on 12/16/03. On 12/16/03, a vaccinee inadvertently received a dose of 0.25ml of Fluvirin. No adverse events had occurred as a result at the time of this report. There was insufficient information to determine the reporter's causality assessment. Update 3/15/04: Further information was received from a health care professional indicating that the vaccinee did not experience any adverse reaction. The vaccinee did not contract influenza and she later received the full dosage of Fluvirin in mid January. No follow up pending. All information received.
Age: 6.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 12/17/03 concerning a 6 year old male vaccinee who inadvertently received a sub-optimal dose of Fluvirin on 12/15/03. On 12/15/03, a vaccinee inadvertently received a dose of 0.25ml of Fluvirin. No adverse events had occurred as a result at the time of this report. There was insufficient information to determine the reporter's causality assessment. Update 3/15/04: Further information was received from a health care professional indicating that the vaccinee did not experience any adverse reaction. The vaccinee did not contract influenza and he later received the full dosage of Fluvirin in mid January. No follow up pending. All information received.
Age: 6.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 12/17/03 concerning a 6 year old female vaccinee who inadvertently received a sub-optimal dose of Fluvirin on 12/15/03. On 12/15/03, a vaccinee inadvertently received a dose of 0.25ml of Fluvirin. No adverse events had occurred as a result at the time of this report. There was insufficient information to determine the reporter's causality assessment. Update 3/15/04: Further information was received from a health care professional indicating that the vaccinee did not experience any adverse reaction. The vaccinee did not contract influenza and she later received the full dosage of Fluvirin in mid January. No follow up pending. All information received.
Age: 6.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 12/17/2003 concerning a 6 year old male vaccinee who inadvertently received a sub-optimal dose of Fluvirin on 12/15/03. On 12/15/03, a vaccinee inadvertently received a dose of 0.25ml of Fluvirin. No adverse events had occurred as a result at the time of this report. There was insufficient information to determine the reporter's causality assessment. Update 3/15/04: Further information was received from a health care professional indicating that the vaccinee did not experience any adverse reaction. The vaccinee did not contract influenza and he later received the full dosage of Fluvirin in mid January. No follow up pending. All information received.
Age: 8.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 12/17/03 concerning an 8 year old female vaccinee who inadvertently received a sub-optimal dose of Fluvirin on 12/15/03. On 12/15/03, a vaccinee inadvertently received a dose of 0.25ml of Fluvirin. No adverse events had occurred as a result at the time of this report. There was insufficient information to determine the reporter's causality assessment. Update 3/15/04: Further information was received from a health care professional indicating that the vaccinee did not experience any adverse reaction. The vaccinee did not contract influenza and she will later receive the full dosage of Fluvirin in mid January. No follow up pending. All information received.
Age: 7.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 12/17/03 concerning a 7 year old male vaccinee who inadvertently received a sub-optimal dose of Fluvirin on 12/15/03. On 12/15/03 a vaccinee inadvertently received a dose of 0.25ml of Fluvirin. No adverse events had occurred as a result at the time of this report. There was insufficient information to determine the reporter's causality assessment. Update 3/15/04: Further information was received from a health care professional indicating that the vaccinee did not experience any adverse reaction. The vaccinee did not contract influenza and he later received the full dosage of Fluvirin in mid January. No follow up pending. All information received.
Age: 4.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a consumer on 12/18/03 concerning a 3 year old female vaccinee who inadvertently received 0.5ml of Fluvirin in the thigh on 12/10/03. On 12/10/03, the vaccinee inadvertently received 0.5ml of Fluvirin in the thigh. At the time of the report no adverse events had been reported. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 1.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 12/18/03 concerning a 1 year old female vaccinee who inadvertently received Fluvirin on 12/16/03. On 12/16/03 the vaccinee inadvertently received Fluvirin. At the time of the report no adverse events had been reported. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Sex: U
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 12/18/03 concerning an unknown number of children, of unknown sex and less than 4 years of age who inadvertently received Fluvirin on an unspecified date. On an unspecified date, an unknown umber of vaccinees inadvertently received Fluvirin. At the time of the report no adverse events have been reported. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Sex: M
Vaccine: FLU3
Symptoms: Injection site induration, Injection site mass, Injection site pain, Injection site swelling
Clinical narrative: A report was received from a health care professional on 12/18/03 concerning a mid-40 year old male vaccinee who developed a large hard, swollen and painful knot on the right thigh around the site of injection immediately after self-administration of Fluvirin on an unspecified date in November 2003. On an unspecified date in November 2003, the vaccinee self-administered Fluvirin into the right thigh. Immediately after administration, the vaccinee developed a large hard, swollen and painful knot around the area of administration that increased in size to 10 inches in diameter. The knot then slowly abated and disappeared in about a week. The same events happened with last year's vaccine but the knot was not as large. At the time of reporting, the vaccinee was not experiencing any symptoms. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 42.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 12/18/03 concerning a 42 year old female vaccinee who received expired Fluvirin on approximately 10/20/03. On approximately 10/20/03 the vaccinee received expired vaccine. The vaccinee did not experience any adverse effects as a result. There was insufficient information to determine the reporter's causality assessment. Update 2/16/04: A follow up report was received from a health care professional indicating that no adverse event had occurred at the time of reporting. No follow up pending. All information received.
Age: 3.0
Sex: U
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 12/19/03 concerning a 3 year old vaccinee of unknown gender who inadvertently received Fluvirin vaccine on an unspecified day in December 2003. On an unspecified day in December 2003, the vaccinee received Fluvirin. No adverse event was observed. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 3.0
Sex: U
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 12/19/03 concerning a 3.5 year old vaccinee of unknown gender who inadvertently received Fluvirin vaccine on an unspecified date in December 2003. On an unspecified date in December 2003, the vaccinee received Fluvirin. No adverse event was observed. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 0.7
Sex: U
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 12/19/03 concerning an 8 month old vaccinee of unknown gender who inadvertently received Fluvirin vaccine on an unspecified day in December 2003. On an unspecified day in December 2003, the vaccinee received Fluvirin. No adverse event was observed. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Sex: U
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 12/19/03 concerning six children of unknown sex and less than 4 years of age who inadvertently received Fluvirin on an unspecified date in December 2003. On an unspecified date in December 2003, the vaccinees inadvertently received Fluvirin. At the time of the report no adverse events had been reported. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site pain, Injection site rash, Injection site swelling
Clinical narrative: A report was received from a health care professional on 12/23/03 concerning a female vaccinee in her forties who experienced a circular rash and swelling at the site of administration approximately 12 to 24 hours after receiving Fluvirin on 12/8/03. Approximately 12 to 24 hours after receiving Fluvirin on 12/8/036 the vaccinee experienced a red, raised circular rash with soreness or tenderness and slight swelling at the site of administration. The vaccinee was treated with 1% hydrocortisone topically and recovered 2-3 days later. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site pain, Injection site rash, Injection site swelling
Clinical narrative: A report was received from a health care professional on 12/23/03 concerning a female vaccinee in her forties who experienced a circular rash and swelling at the site of administration approximately 12 to 24 hours after receiving Fluvirin on 12/8/03. Approximately 12 to 24 hours after receiving Fluvirin on 12/8/03 the vaccinee experienced a red, raised circular rash with soreness or tenderness and slight swelling at the site of administration. The vaccinee was treated with 1% hydrocortisone topically and recovered 2-3 days later. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site pain, Injection site rash, Injection site swelling
Clinical narrative: A report was received from a health care professional on 12/23/03 concerning a female vaccine in her forties who experienced a circular rash and swelling at the site of administration approximately 12 to 24 hours after receiving Fluvirin on 12/20/03. Approximately 12 to 24 hours after receiving Fluvirin on 12/20/03 the vaccinee experienced a red, raised circular rash with soreness or tenderness and slight swelling at the site of administration. The vaccinee was treated with 1% hydrocortisone topically and recovered 2-3 days later. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 1.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 12/23/03 concerning a 1 year old male vaccinee who was inadvertently administered Fluvirin on 12/8/03. On 12/8/03, the vaccinee was inadvertently administered Fluvirin. No adverse events have occurred, as a result at the time of the report. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 3.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 12/23/03 concerning a 3 year old male vaccinee who was inadvertently administered Fluvirin on 12/18/03. On 12/18/03 the vaccinee was inadvertently administered Fluvirin. No adverse events have occurred as a result at the time of the report. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 5.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 12/23/03 concerning a 5 year old male vaccinee who was administered half of the correct dose of Fluvirin on 12/8/03. On 12/8/03, the vaccinee was administered 0.25ml of Fluvirin. No adverse events have occurred as a result at the time of the report. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 0.9
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a consumer on 12/23/03 concerning an 11 month old male vaccinee who inadvertently received Fluvirin on 12/8/03. On 12/8/03, the vaccinee inadvertently received Fluvirin. At the time of the report no adverse events had been reported. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Sex: U
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 12/30/03 concerning approximately 10 children of unspecified sex and under 4 years of age who inadvertently received Fluvirin on an unspecified date in December 2003. On an unspecified date in December 2003, approximately 10 children inadvertently received Fluvirin. At the time of the report no adverse events had been reported. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 1.5
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 1/2/04 concerning an 18 month old female vaccinee who inadvertently received Fluvirin vaccine on 12/2/03. On 12/2/03 the vaccinee received 0.25ml Fluvirin. No adverse events were reported. There was insufficient information to determine the reporter's causality assessment. Follow up pending.
Age: 1.03
Sex: M
Vaccine: PNC
Symptoms: Injection site erythema, Injection site mass
Clinical narrative: Quarter sized area of redness induration at injection site.
Age: 44.0
Sex: M
Vaccine: HEP
Symptoms: Hypoaesthesia, Injection site pain, Nasal congestion, Rhinorrhoea
Clinical narrative: Pt. reported local reaction at injection site with pain and numbness from shoulder to upper chest beginning in the evening after the shot was administered. Also reported upper respiratory congestion and rhinorrhea beginning at same time. Vaccine was administered on 12/8/2004 at 10 AM. Most symptoms dissipated later that same evening with slight soreness at injection site remaining the next morning.
Age: 0.31
Sex: F
Vaccine: IPV, PNC
Symptoms: Irritability, Screaming, Swelling
Clinical narrative: Local swelling, screaming and irritable for 3 days.
Age: 60.0
Sex: F
Vaccine: FLU3
Symptoms: Arthralgia
Clinical narrative: Flu shot administered in left deltoid 10/28/2004. On 10/29/2004 had pain in right hip/SI joint. Pain worsened over next week.  Patient believes that flu shot activated inflammatory response.
Age: 34.0
Sex: F
Vaccine: FLUN3
Symptoms: Chills, Headache, Nasal congestion, Pain, Pharyngolaryngeal pain
Clinical narrative: Within 3 hours of vaccination developed, fever, chills, apalling headache,total body ache and sore throat.  Lasted for about 3 days, still had sore throat and nasal congestion for about 10 days.
Age: 34.0
Sex: F
Vaccine: FLUN3
Symptoms: Pyrexia
Clinical narrative: Within 3 hours of vaccination developed, fever, chills, apalling headache,total body ache and sore throat.  Lasted for about 3 days, still had sore throat and nasal congestion for about 10 days.
Age: 4.0
Sex: M
Vaccine: FLU3
Symptoms: Urticaria
Clinical narrative: PATIENT RECEIVED FLU VACCINE AND ABOUT 4 HOURS LATER BROKE OUT IN HIVES.  PATIENT CAME TO CLINIC.  PATIENT CONTACTED PRIVATE PROVIDER AND WAS ADVISED TO GIVE CHILD BENADRYL AND CONTACT OUR OFFICE TO COMPLETE VAERS.
Age: 0.19
Sex: M
Vaccine: DTAP, HBHEPB, IPV, PNC
Symptoms: Sudden infant death syndrome
Clinical narrative: Patient in office for routine well child check and immunizations on 12/6/04. Sudden infant death 12/9/04.
Age: 0.23
Sex: M
Vaccine: DTAPHEPBIP
Symptoms: Unevaluable event
Clinical narrative: Death during night; unknown cause. Autopsy pending.
Age: 1.95
Sex: F
Vaccine: PNC
Symptoms: Agitation, Anorexia, Bacterial infection, CSF test abnormal, Cough
Clinical narrative: Acute pneumococcal meningitis; onset 11/23/04. Hospitalized 2 weeks; full recovery. Information from discharge summary states hyponatrenmia, fever, diarrhea, nuchal rigidity. Information from medicl records states increased cough, congestion, runny nose, decreased orl intake, agitation, withdrawn and otitis media.
Age: 1.95
Sex: F
Vaccine: PNC
Symptoms: Diarrhoea, Drug ineffective, Emotional disorder, Hyponatraemia, Laboratory test abnormal
Clinical narrative: Acute pneumococcal meningitis; onset 11/23/04. Hospitalized 2 weeks; full recovery. Information from discharge summary states hyponatrenmia, fever, diarrhea, nuchal rigidity. Information from medicl records states increased cough, congestion, runny nose, decreased orl intake, agitation, withdrawn and otitis media.
Age: 1.95
Sex: F
Vaccine: PNC
Symptoms: Meningitis, Nasal congestion, Nuchal rigidity, Otitis media, Pyrexia
Clinical narrative: Acute pneumococcal meningitis; onset 11/23/04. Hospitalized 2 weeks; full recovery. Information from discharge summary states hyponatrenmia, fever, diarrhea, nuchal rigidity. Information from medicl records states increased cough, congestion, runny nose, decreased orl intake, agitation, withdrawn and otitis media.
Age: 1.95
Sex: F
Vaccine: PNC
Symptoms: Rhinitis
Clinical narrative: Acute pneumococcal meningitis; onset 11/23/04. Hospitalized 2 weeks; full recovery. Information from discharge summary states hyponatrenmia, fever, diarrhea, nuchal rigidity. Information from medicl records states increased cough, congestion, runny nose, decreased orl intake, agitation, withdrawn and otitis media.
Age: 51.0
Sex: M
Vaccine: FLU3
Symptoms: Dysphagia, Eructation, Headache, Throat tightness
Clinical narrative: At approximately 1:30 PM my throat area between roof of mouth and collar bones began to tighten and construct and swallowing became difficult. Throat felt compressed. I drank water delayed eating till 7:00PM, Symptoms and headache disappeared about 6:30PM, belching was a serious problem.
Age: 1.25
Sex: M
Vaccine: DTAP, FLU3, PNC, VARCEL
Symptoms: Cough, Decreased appetite, Dehydration, Irritability, Pyrexia
Clinical narrative: Developed fever about 4 hrs after shot, temp to 104.3 by 23:00. Also developed runny nose, cough and very fussy. Poor appetite today, drinking less, 3 wet diapers today.
Age: 1.25
Sex: M
Vaccine: DTAP, FLU3, PNC, VARCEL
Symptoms: Rhinorrhoea
Clinical narrative: Developed fever about 4 hrs after shot, temp to 104.3 by 23:00. Also developed runny nose, cough and very fussy. Poor appetite today, drinking less, 3 wet diapers today.
Age: 28.0
Sex: M
Vaccine: FLU3
Symptoms: Feeling hot, Injection site rash, Pain, Pruritus, Rash papular
Clinical narrative: The day after being given the flu shot (11/4), he developed a papular rash approximately 3" long and 1.5" wide, next to the injection site. He reports no itching, burning, pain, warmth.
Age: 28.0
Sex: M
Vaccine: FLU3
Symptoms: Skin burning sensation
Clinical narrative: The day after being given the flu shot (11/4), he developed a papular rash approximately 3" long and 1.5" wide, next to the injection site. He reports no itching, burning, pain, warmth.
Age: 0.54
Sex: M
Vaccine: DTAPHEPBIP, FLU3, PNC
Symptoms: Urticaria
Clinical narrative: Hives all over body: given Benadryl and Orapred
Age: 41.0
Sex: F
Vaccine: FLU3
Symptoms: Blister, Injection site erythema, Injection site induration, Injection site pain, Injection site vesicles
Clinical narrative: Had received a flu shot and 24 hour later the area around the site was red, hard, warm and very sore. It kept getting larger and pretty much involved the whole upper arm. There was a small blister in the center of reddened area.
Age: 41.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site warmth
Clinical narrative: Had received a flu shot and 24 hour later the area around the site was red, hard, warm and very sore. It kept getting larger and pretty much involved the whole upper arm. There was a small blister in the center of reddened area.
Age: 1.3
Sex: F
Vaccine: DTAP, FLU3
Symptoms: Irritability, Somnolence
Clinical narrative: Fussy after shots, took a nap. Parent woke child to go out to eat while driving, child was fussy, then suddenly stopped. Mom looked at child: acted like she fell asleep, but her face looked funny. Mom shook child 20-30 sec and woke her. Fussy again. Ate a little , but mom still worried. Called doctor and was advised to go to ER. Child acted okay while there, lab and EKG were WNL. Advised to watch child and report any worries.
Age: 45.0
Sex: M
Vaccine: FLUN3
Symptoms: Chills, Laboratory test abnormal, Malaise, Pneumonia, Pyrexia
Clinical narrative: By mid noon 12hrs low grade temp, chills, 32 hours, 102 temp, chills, malaise, high temp for 3 days, respiratory symptoms began within 24 hours, sniffles, irritable throat. 72 hours began Zithromax for diagnosed pneumonia.
Age: 45.0
Sex: M
Vaccine: FLUN3
Symptoms: Rhinorrhoea, Upper respiratory tract infection
Clinical narrative: By mid noon 12hrs low grade temp, chills, 32 hours, 102 temp, chills, malaise, high temp for 3 days, respiratory symptoms began within 24 hours, sniffles, irritable throat. 72 hours began Zithromax for diagnosed pneumonia.
Age: 69.0
Sex: M
Vaccine: FLU3
Symptoms: Chest discomfort, Dizziness, Dyspnoea, Pyrexia
Clinical narrative: Approximately 6 hours after vaccination: felt dizzy and tightness in chest very difficult breathing and a low fever. Took Tylenol pm, next day seemed okay.
Age: 0.58
Sex: F
Vaccine: DTAPHEPBIP, FLU3, PNC
Symptoms: Urticaria
Clinical narrative: Generalized urticaria but no dyspnea: Benadryl prescribed
Age: 2.0
Sex: M
Vaccine: DTAP, FLUX, HEPA
Symptoms: Feeling hot, Injection site reaction, Skin discolouration, Swelling
Clinical narrative: Left thigh swollen, pink, hot to touch, not tender. Advised use of cold pack,Benadryl if itchy or uncomfortable , return if pain or fever. DTaP only vax in left thigh.
Age: 1.19
Sex: F
Vaccine: FLU3, HIBV, MMR, VARCEL
Symptoms: Infection, Injection site erythema, Injection site induration, Injection site mass, Injection site pain
Clinical narrative: 10/30: Pt seen by MD: left thigh hard, tender red lump around 2cm x 1.5cm, painful to touch. Advised hot soaks to leg vaccine site. Questionably infected. 10/31: Doctor spoke to mom. Still hard, red, tender. Advised to continue hot soaks and to recheck, would consider oral prescription (not yet). 11/5: mom called: still has lump, advised lump could stay x several months.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV
Symptoms: Swelling
Clinical narrative: Right arm is swollen on upper arm and 0.5 of forearm. Marked area 0.5 of arm, not warm to touch. Elbow with full flexion. Treated with Orapred, Atarax, ice compress.
Age: 5.0
Sex: M
Vaccine: IPV, MMR
Symptoms: Erythema, Flushing, Pruritus, Urticaria
Clinical narrative: Flushed, red: head to toe urticaria in 2 hours taken to ER: given epinephrine, antihistamine and steroids. Did complain of itching today 12/06/2004 at 6:30 am.
Age: 0.25
Sex: U
Vaccine: DTAP, HBHEPB, IPV, PNC
Symptoms: Convulsion, Eye movement disorder, Myoclonus
Clinical narrative: About 30 hours after vaccine given, child had episode consistent with brief myoclonic seizure: would extend help for around 10 seconds and did this 3-4 times x 15-20" period. During episodes, eyes would consistently roll back. On 2nd day after injections, he has about 10 episodes upon awakening. Looks normal in clinic. No 20C with episodes. No episodes in clinic today (two days after vaccine given). No Treatment indicated.
Age: 2.0
Sex: M
Vaccine: HIBV, PNC
Symptoms: Cellulitis, Feeling hot, Injection site erythema, Injection site swelling
Clinical narrative: shot of the Hib vaccine administered in the right thigh on 11/30/2004. Symptoms started with swelling, redness at the site of injection. Positive warmth, increasing in size. No fevers otherwise healthy. Appeared like a cellulitis and was given antibiotics.
Age: 4.0
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Injection site erythema, Urticaria
Clinical narrative: 4cm red wheel around DTaP site on RL
Age: 0.2
Sex: M
Vaccine: DTAP, HIBV, IPV, PNC
Symptoms: Tremor
Clinical narrative: Mother noted the baby to have fine tremor of the head about a week ago. Mother brought baby 12/01/04. Noted flighty tremors of head 1-2 seconds. Beg alert while having the tremors. There was no fever after episode. Patient referred to Neurologist.
Age: 0.87
Sex: M
Vaccine: PNC
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: 5" red , swollen painful at site of Prevnar Injection.
Age: 5.0
Sex: M
Vaccine: DTAP
Symptoms: Erythema, Feeling hot, Pain, Swelling
Clinical narrative: Left thigh generalized swelling, (34 cm circumference vs. 31cm on right), warmth, redness, pain.
Age: 23.0
Sex: F
Vaccine: SMALL
Symptoms: Rash erythematous, Rash pustular
Clinical narrative: Received small pox vaccine on 11/17; Read major reaction 11/24/2004 on 11/25 started to breakout in small pustules all over body. Seen 11/29 diffuse areas of erythematous pustular lesions back, chest, neck, arms, legs. No LA, afebrile, off work until 12/3, re-eval; pictures taken 12/3/04 pustular rash healed sm papules
Age: 5.0
Sex: F
Vaccine: DTAP, DTAPHEPBIP, HEP, MMR
Symptoms: Erythema, Feeling hot, Pain, Swelling, Tenderness
Clinical narrative: Patient had complaint of soreness of arm since 12/9/04. Patient's mother noticed redness and swelling 12/11/04. Pt was advised to put ice on site and keep an eye on if worsen, go to ER. (sight was red, warm to touch, swollen, pain)
Age: 80.0
Sex: F
Vaccine: PPV
Symptoms: Erythema, Injection site oedema, Injection site pain
Clinical narrative: Pt started having pain in left arm afternoon after shot was given in the AM. By the next day Pt noticed redness, swelling and increased pain in mid left arm.
Age: 58.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema
Clinical narrative: Lg erythema right or left below injection site
Age: 68.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Pyrexia
Clinical narrative: Erythema below injection site 7x6" in diameter down into mid part of the brachium, temp 99.2
Age: 60.0
Sex: M
Vaccine: PPV
Symptoms: Injection site erythema, Injection site oedema, Injection site rash, Pyrexia, Tenderness
Clinical narrative: Large swelling of Left deltoid muscle12" diameter, red and tender to touch, increased WBC 21.9, fever 99.1. Oct 7/04, rash at injection site.
Age: 60.0
Sex: M
Vaccine: PPV
Symptoms: White blood cell count increased
Clinical narrative: Large swelling of Left deltoid muscle12" diameter, red and tender to touch, increased WBC 21.9, fever 99.1. Oct 7/04, rash at injection site.
Age: 4.0
Sex: F
Vaccine: DTAP, IPV
Symptoms: Pruritus, Pyrexia
Clinical narrative: Fever, itching, 7 days after vaccine
Age: 4.0
Sex: F
Vaccine: HEPA
Symptoms: Swelling, Urticaria
Clinical narrative: 1/2 hour after receiving Hep A, neck swelled with big hives. Gave Benadryl and luke warm bath. Then in AM, woke up with big hive on eye and all down back. Gave more Benadryl and bath again.
Age: 72.0
Sex: F
Vaccine: PPV
Symptoms: Erythema, Swelling
Clinical narrative: Localized erythema and swelling proximal to injection site developed 8 hours after injection. Patient required therapy with Benadryl PO.
Age: 1.43
Sex: F
Vaccine: DTAP, HBHEPB, PNC
Symptoms: Injection site mass
Clinical narrative: Right outer thigh lump: not tender doctor reassured patient: not dangerous, will subside with treatment.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMR
Symptoms: Erythema, Feeling hot, Pain, Rash
Clinical narrative: Patient complained of rash, redness, pain and warmth RA. Advised to apply ice to area and OTC for pain or discomfort. Return if worsens.
Age: 1.08
Sex: M
Vaccine: DTAP
Symptoms: Erythema, Feeling hot, Swelling
Clinical narrative: Seen at Greenwich hospital due to swelling LL Noted to be warm to area, a febrile, some erythema persists on exam 8/11 but generally improved. Advised to use Tylenol supp for temp.
Age: 1.55
Sex: M
Vaccine: DTAP
Symptoms: Unevaluable event
Clinical narrative: Mom stated at later date (8/25/04: 24 months appointment) that a reaction to DTaP occurred.
Age: 1.03
Sex: F
Vaccine: HIBV, MMR, VARCEL
Symptoms: Erythema, Swelling
Clinical narrative: Patient returned to office, LT red and swollen not tender. Advised to apply ice and give OTC for discomfort. To return in worsens.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMR
Symptoms: Erythema, Injection site induration, Swelling
Clinical narrative: T/C received from mom: stating LT, red , swollen, hard to touch. Advised to apply ice and can give OTC for discomfort to return if worsens.
Age: 1.64
Sex: F
Vaccine: DTAP
Symptoms: Erythema, Swelling
Clinical narrative: T/C received form mom, LL : redness and swelling, not in distress. Advised to use cool compresses.
Age: 1.52
Sex: M
Vaccine: DTAP, HIBV, PNC
Symptoms: Injection site erythema, Injection site warmth
Clinical narrative: T/C received from mom: states, immunization site red, hot to touch, no temp, afebrile, okay to use OTC. Return if worsens
Age: 74.0
Sex: F
Vaccine: FLUX
Symptoms: Chills, Cough, Diarrhoea, Headache, Malaise
Clinical narrative: Had flu shot on wed. (Dec 1) and the next sat I was very sick, chills, tight cough, headache, muscle aches in my whole body. Two day had loose stools. It is a week later today a still not feeling better.